We are pleased to announce that the Organization for Small & Medium Enterprises and Regional Innovation, JAPAN (“SMRJ”) has decided to invest up to ¥2.0B in our second fund, ALHF II. We are grateful for SMRJ’s continued support of our endeavors, following their investment in our first fund, ALHF I. SMRJ has been instrumental in fostering the growth of the health and medical venture ecosystem, aiming to develop world-class life science ventures in partnership with Axil.